Cardiac fibroblasts: from development to heart failure.

Area of Science:

• Cardiovascular Biology
• Fibrosis Research
• Cellular Origins

Background:

• Cardiac fibroblasts are key extracellular matrix (ECM) producers in the heart.
• Myocardial fibrosis, due to excessive fibroblast accumulation, is a major clinical issue in pressure overload conditions.
• Understanding fibroblast generation mechanisms is crucial for developing effective anti-fibrotic therapies.

Purpose of the Study:

• To review recent findings on the origins of cardiac fibroblasts.
• To emphasize the role of fibroblast origins in the context of pressure overload.
• To discuss the implications for developing novel anti-fibrotic treatments.

Main Methods:

• Review of current scientific literature.
• Focus on studies investigating fibroblast origins in pressure overload models.
• Analysis of proposed mechanisms for fibroblast generation.

Main Results:

• Recent evidence suggests activation of resident cardiac fibroblasts is a primary driver of fibrosis.
• De novo generation of fibroblasts from endothelial and circulating hematopoietic cells also significantly contributes to fibrosis.
• Multiple cellular origins contribute to the fibroblast pool during cardiac pressure overload.

Conclusions:

• Fibrosis in pressure overload is driven by both resident fibroblast activation and de novo fibroblast generation.
• Elucidating these diverse origins is critical for advancing anti-fibrotic therapeutic strategies.
• Targeting specific fibroblast origins may offer new avenues for treating myocardial fibrosis.